Detalhe da pesquisa
1.
Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines.
J Virol
; 98(1): e0147823, 2024 Jan 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38085509
2.
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials.
PLoS Pathog
; 19(6): e1011469, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37384759
3.
Dependence on a variable residue limits the breadth of an HIV MPER neutralizing antibody, despite convergent evolution with broadly neutralizing antibodies.
PLoS Pathog
; 18(9): e1010450, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054228
4.
Shared N417-Dependent Epitope on the SARS-CoV-2 Omicron, Beta, and Delta Plus Variants.
J Virol
; 96(15): e0055822, 2022 08 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35867572
5.
Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.
Biochem Biophys Res Commun
; 566: 135-140, 2021 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34119826
6.
Impaired Transplacental Transfer of Respiratory Syncytial Virus-neutralizing Antibodies in Human Immunodeficiency Virus-infected Versus -uninfected Pregnant Women.
Clin Infect Dis
; 69(1): 151-154, 2019 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561563
7.
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351).
N Engl J Med
; 384(22): 2161-2163, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33826816
8.
The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants.
Clin Infect Dis
; 63(suppl 4): S165-S173, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27838669
9.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
PLOS Glob Public Health
; 4(4): e0002703, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38603677
10.
Novavax NVX-COV2373 triggers neutralization of Omicron sub-lineages.
Sci Rep
; 13(1): 1222, 2023 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681693
11.
Despite delayed kinetics, people living with HIV achieve equivalent antibody function after SARS-CoV-2 infection or vaccination.
Front Immunol
; 14: 1231276, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37600825
12.
Antibody-dependent cellular cytotoxicity against SARS-CoV-2 Omicron sub-lineages is reduced in convalescent sera regardless of infecting variant.
Cell Rep Med
; 4(1): 100910, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36603577
13.
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants.
medRxiv
; 2023 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38045321
14.
Enhanced neutralization potency of an identical HIV neutralizing antibody expressed as different isotypes is achieved through genetically distinct mechanisms.
Sci Rep
; 12(1): 16473, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36182959
15.
Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.
Sci Transl Med
; 14(631): eabj6824, 2022 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931886
16.
Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
Nat Med
; 28(9): 1924-1932, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35995954
17.
Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage.
Nat Commun
; 13(1): 1976, 2022 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35396511
18.
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
Nat Med
; 27(4): 622-625, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33654292
19.
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma.
bioRxiv
; 2021 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33501446
20.
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies.
bioRxiv
; 2021 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33688657